VahatiCor

Santa Clara, United States

VahatiCor develops the A-FLUX Reducer System for coronary microvascular dysfunction relief.

$23.0M raised

Nov 2025

Series B

Top Investors

S3 VenturesIntuitive Ventures

19,000+ verified contacts

Emails, phones & LinkedIn profiles

How much funding has VahatiCor raised?

VahatiCor has raised $23.0M in total funding. The most recent round was Series B. The last funding was announced in November 2025.

Who are VahatiCor's investors?

VahatiCor's investors include S3 Ventures, Intuitive Ventures.

Where is VahatiCor headquartered?

VahatiCor is headquartered in Santa Clara, United States.

What does VahatiCor do?

VahatiCor develops the A-FLUX Reducer System for coronary microvascular dysfunction relief.

What stage is VahatiCor at?

VahatiCor is at the Series B stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated November 18, 2025.

MLA

"VahatiCor — Funding & Investors." VCBacked, November 18, 2025, https://www.vcbacked.co/company/vahaticor. Accessed June 14, 2026.

APA

VCBacked. (2025). VahatiCor — Funding & Investors. Retrieved June 14, 2026, from https://www.vcbacked.co/company/vahaticor

Wikipedia (cite web)

{{cite web |title=VahatiCor — Funding & Investors |url=https://www.vcbacked.co/company/vahaticor |website=VCBacked |access-date=June 14, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated November 18, 2025.